A phase 2 liver trial where the add-on drug didn't help — and the base drug quietly did
Read the Sunday Brief →

Study wrapper · #985

Restoring cardiolipin homeostasis mitigates cerebral ischemia-reperfusion injury by suppressing ATG5-mediated neuronal autophagy-dependent ferroptosis.

Dong W, Zhang W, Huang L, et al. Journal of advanced research. 2026.
Weak / noneAnimal (in vivo)Mentions: SS-31

Editor's note

An animal and cell study in which SS-31 is a central intervention for preserving cardiolipin after ischemia-reperfusion. Evidence is preclinical and mechanistic. A solid data point for SS-31 in stroke research.

Plain-language abstract

In mouse and cell stroke models, the cardiolipin-targeting peptide SS-31 preserved cardiolipin and was associated with reduced ischemia-reperfusion brain injury.